Seeking Alpha

EBIO
  Eleven Biotherapeutics, Inc. - NASDAQ

9/2/2014, 1:18 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
EBIO vs. ETF Alternatives
Company Description
Eleven Biotherapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it applies to the discovery and development of protein therapeutics to treat diseases of the eye.
Sector: Healthcare
Industry: Biotechnology
Country: United States